Europe/Asia USA
Bachem AG Bachem Americas, Inc.
Hauptstrasse 144 3132 Kashiwa Street
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA
Tel +41 61 935 2323 Tel +1 888 422 2436
Fax +41 61 935 2325 +1 888 4BACHEM
E-mail sales.ch@bachem.com +1 310 539 4171
  Fax +1 310 539 9428
  E-mail sales.us@bachem.com

DETAIL

Jerini

18. Mar 2004
Jerini and Bachem announce collaboration for Icatibant production

Jerini AG and Bachem AG today announced a collaboration agreement for production and supply of Jerini´s lead compound Icatibant. At present, Icatibant is tested in several clinical trials to treat refractory ascites in liver cirrhosis as well as hereditary angioedema. By 2006 Jerini plan to bring Icatibant to market.

“With Bachem we have gained a reliable and experienced partner to secure fast high-quality production of Ica-tibant. Furthermore, Bachem is well experienced in regulatory affaires and procedures”, said Jochen Knolle, PhD, Jerini´s head of R&D.

“We are very pleased to contribute to further developing Icatibant by producing the substance and supporting all phases from clinical studies to market introduction. Icatibant for us seems to be a very promising drug compound”, said Walter Isler, Head of Marketing and Sales, Bachem AG.

 

Press Release